BioNTech SE (BNTX) Receives a Hold from J.P. Morgan
In a report released today, Jessica Fye from J.P. Morgan maintained a Hold rating on BioNTech SE (BNTX – Research Report), with a price target ...
Vertex Pharmaceuticals Incorporated (VRTX) CEO Reshma Kewalramani Hosts 43rd Annual J.P. Morgan Healthcare Conference (Transcript)
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) 43rd Annual J.P. Morgan Healthcare Conference January 13, 2025 10:30 AM ETCompany ParticipantsDr.
Hosted on MSN4mon
Halozyme cut to Neutral at J.P. Morgan on valuation
Shares of Halozyme Therapeutics (NASDAQ:HALO) trended lower on Thursday after J.P. Morgan downgraded the ... However, analyst Jessica Fye raised her price target on HALO to $57 from $52 per ...
Business Insider1mon
J.P. Morgan Reaffirms Their Hold Rating on BioNTech SE (BNTX)
J.P. Morgan analyst Jessica Fye maintained a Hold rating on BioNTech SE (BNTX – Research Report) today and set a price target of $122.00. The company’s shares closed today at $117.39.